Date published: 2025-11-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

MIP-5 Activators

MIP-5 activators encompass a set of chemical compounds that specifically target or indirectly modulate the expression or activity of the MIP-5 chemokine. The core principle guiding the impact of these activators is the common cellular pathway of NF-κB activation. As a pivotal transcription factor, NF-κB plays a central role in immune responses, inflammation, and more critically, in the transcriptional regulation of chemokines, including MIP-5. When activated by various stimulants, NF-κB migrates to the nucleus and binds to specific DNA sequences, particularly in the promoter regions of target genes. In the context of MIP-5, NF-κB binding to its promoter enhances its transcription, thereby elevating its levels.

MIP-5 activators, as outlined here, primarily function by engaging different Toll-like receptors (TLRs), a family of pattern recognition receptors (PRRs) that detect microbial components and instigate innate immune responses. Each TLR has its unique ligand specificity, from bacterial cell wall components like LPS and LTA (targeting TLR4 and TLR2 respectively) to viral mimetics like Poly(I:C) (targeting TLR3). Activation of these receptors invariably converges on a common downstream effect: NF-κB pathway stimulation. The variety of these activators underscores the redundancy and interconnectedness of the body's defense mechanisms. Additionally, some compounds like PMA bypass TLRs but still stimulate the NF-κB pathway by targeting protein kinases. Such an integrated system ensures that any perturbation, be it microbial invasion or cellular stress, is aptly met with an appropriate chemokine response, signified in this context by MIP-5 production.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$96.00
$166.00
$459.00
$1615.00
12
(2)

LPS stimulates the Toll-like receptor 4 (TLR4) pathway, which leads to the activation of NF-κB. This, in turn, upregulates the transcription of various chemokines, including MIP-5.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates the PKC pathway, which can stimulate the NF-κB pathway. As NF-κB can bind to the promoter region of MIP-5, PMA indirectly leads to enhanced transcription of MIP-5.

Polyinosinic acid - polycytidylic acid sodium salt, double-stranded

42424-50-0sc-204854
sc-204854A
10 mg
100 mg
$139.00
$650.00
2
(1)

Poly(I:C) mimics double-stranded RNA, activating TLR3. This leads to downstream activation of NF-κB, which can enhance the transcription of MIP-5.

Lipoteichoic acid

56411-57-5sc-507479
5 mg
$248.00
(0)

LTA stimulates the TLR2 pathway, leading to NF-κB activation. NF-κB subsequently binds to the promoter region of various chemokines, including MIP-5, leading to its increased transcription.

Zymosan

9010-72-4sc-296863
sc-296863A
100 mg
1 g
$97.00
$587.00
1
(0)

Zymosan activates the TLR2/6 pathway. Activation of this pathway can lead to the upregulation of NF-κB which, in turn, promotes MIP-5 transcription.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$66.00
$278.00
6
(1)

Imiquimod is a TLR7 agonist. Its activation results in NF-κB stimulation, which can bind to the promoter region of MIP-5, promoting its transcription.

Gardiquimod

1020412-43-4sc-221663
sc-221663A
sc-221663B
sc-221663C
sc-221663D
sc-221663E
sc-221663F
25 mg
50 mg
100 mg
250 mg
5 g
10 g
25 g
$154.00
$276.00
$506.00
$1154.00
$19743.00
$32136.00
$69366.00
1
(1)

Gardiquimod activates TLR7, leading to the activation of NF-κB. NF-κB can bind to the promoter region of MIP-5, increasing its transcription.

CL097

1026249-18-2sc-507394
5 mg
$135.00
(0)

CL097 is a TLR7/8 agonist. It stimulates the NF-κB pathway, which can enhance the transcription of MIP-5 by binding to its promoter region.